Fonar Corporation (FONR) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Fonar Corporation  (NASDAQ: FONR)


Fonar's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Fonar's ROI in the third quarter of 2026?
Fonar Corporation achieved a return on average invested assets (ROI) of 4.53 % in its third quarter of 2026, which is below Fonar's average return on investment, which stands at 63.23%.

ROI decreased relative to the period ending Dec 31 2025, due to the decline in net income.

Within the Healthcare sector 140 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 395 to 1091.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter		 (Mar 31 2025)
III. Quarter
Y / Y Investment Change TTM 0.53 % 0.95 % 1.01 % 2.07 % 3.37 %
Y / Y Net Income Change TTM -20.15 % -9.11 % 8.55 % 146.31 % 330.14 %
Investment (TTM) in Millions 189 189 188 187 189
Return On Investment (TTM) 4.53 % 4.92 % 4.7 % 5.41 % 5.7 %
FONR's Overall Ranking # 1091 # 395 # 1192 # 1099 # 1152
Seq. Investment Change TTM -0.04 % 0.53 % 0.03 % 0.01 % 0.38 %
Seq. Net Income Change TTM -7.99 % 5.2 % -13.11 % -5.05 % 4.73 %
Net Income (TTM) in Millions 9 9 9 10 11

FONR Company Profile >> Back to FONR Roi Comparisons >> See Annual FONR Return On Investment



Return On Investment FONR's Ranking
Within: No.
Industry # 42
Sector # 141
Overall # 1091

Return On Investment Statistics
High Average Low
357.82 %
63.23 %
4.53 %
(Mar 31 2019)   (Mar 31 2026)







Financial Statements
Fonar's III. Quarter Investments $ 189 Millions FONR's Balance sheet
Fonar's III. Quarter Income $ 2 Millions Quarterly FONR's Income Statement
FONR's Income by Division See FONR's Income by Division


FONR Annual Return On Investment (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022		 (Jun 30 2021)
2021
Total Investments in Millions 187 187 178 179 166
Y / Y Investment Growth 0.04 % 5.25 % -0.37 % 7.29 % 2.94 %
Net Income in Millions 10 14 12 17 14
Y / Y Net Income Growth -28.06 % 16.25 % -29.64 % 26.04 % 16.82 %
Annual Return On Investment 5.42 % 7.53 % 6.82 % 9.65 % 8.22 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 5.42 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FONR's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FONR's Competitors
Subscribers only: Roi for Fonar's Suppliers
Subscribers only: Return On Investment for FONR's Customers

Other Ratios
FONR's Roa FONR's Inventory Turnover Ratio FONR's Growth Rates FONR's Dividend Statistics
FONR's Profitability Ratios FONR's Asset Turnover Ratio FONR's Dividend Growth
FONR's Roe FONR's Valuation Ratios FONR's Financial Strength Ratios FONR's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI
Encompass Health Corporation  12.43 %
Globus Medical Inc   12.37 %
Regeneron Pharmaceuticals Inc   12.19 %
Medinotec Inc   12.13 %
Msa Safety Inc  12.11 %
Healthcare Services Group Inc   12.09 %
Amgen Inc   12.04 %
Alpha Pro Tech Ltd   11.97 %
Kiniksa Pharmaceuticals International Plc  11.92 %
Prestige Consumer Healthcare Inc   11.89 %
Mimedx Group Inc   11.75 %
Ufp Technologies Inc   11.69 %
Ligand Pharmaceuticals Incorporated  11.46 %
Cryoport inc   11.23 %
Solventum Corporation  11.19 %
Nature s Sunshine Products inc   11.05 %
Bristol myers Squibb Company  10.72 %
Lemaitre Vascular Inc   10.60 %
Dr Reddy s Laboratories Limited  10.30 %
Siga Technologies Inc  10.04 %
Align Technology inc   9.99 %
Boston Scientific Corporation  9.95 %
Pacific Health Care Organization Inc  9.95 %
3m Company  9.80 %
Infusystem Holdings Inc  9.68 %
National Healthcare Corp  9.67 %
Merck and Co Inc   9.58 %
Penumbra Inc  9.57 %
Tenet Healthcare Corp  9.31 %
Viemed Healthcare Inc   9.21 %

Date modified: 2026-09-26T06:53:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.